SE304513B - - Google Patents

Info

Publication number
SE304513B
SE304513B SE27767A SE27767A SE304513B SE 304513 B SE304513 B SE 304513B SE 27767 A SE27767 A SE 27767A SE 27767 A SE27767 A SE 27767A SE 304513 B SE304513 B SE 304513B
Authority
SE
Sweden
Application number
SE27767A
Inventor
A Gagneux
F Haefliger
C Eugster
Original Assignee
Geigy Ag J R
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geigy Ag J R filed Critical Geigy Ag J R
Publication of SE304513B publication Critical patent/SE304513B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/12—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE27767A 1963-12-06 1967-01-09 SE304513B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1495463A CH427803A (de) 1963-12-06 1963-12-06 Verfahren zur Herstellung eines neuen Isoxazolderivates

Publications (1)

Publication Number Publication Date
SE304513B true SE304513B (da) 1968-09-30

Family

ID=4405150

Family Applications (3)

Application Number Title Priority Date Filing Date
SE1469364A SE301652B (da) 1963-12-06 1964-12-04
SE27667A SE303507B (da) 1963-12-06 1967-01-09
SE27767A SE304513B (da) 1963-12-06 1967-01-09

Family Applications Before (2)

Application Number Title Priority Date Filing Date
SE1469364A SE301652B (da) 1963-12-06 1964-12-04
SE27667A SE303507B (da) 1963-12-06 1967-01-09

Country Status (12)

Country Link
US (1) US3242190A (da)
AT (2) AT250348B (da)
BE (1) BE656759A (da)
CH (1) CH427803A (da)
DE (1) DE1445848A1 (da)
DK (4) DK106797C (da)
ES (5) ES306820A1 (da)
FR (2) FR1427775A (da)
GB (1) GB1034939A (da)
IL (1) IL22568A (da)
NL (1) NL6414138A (da)
SE (3) SE301652B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL130992C (da) * 1964-09-14
DK150615C (da) * 1982-10-26 1987-11-09 Cheminova As Fremgangsmaade til fremstilling af substituerede 3-isoxazololer
KR20030059290A (ko) 2000-11-30 2003-07-07 화이자 프로덕츠 인코포레이티드 Gaba 작용제 및 소르비톨 데하이드로게나제 억제제의혼합물
AP2001002359A0 (en) 2000-11-30 2001-12-31 Pfizer Prod Inc Combination of gaba agonists and aldose reductase inhibitors.
CA2525366A1 (en) * 2003-05-16 2004-11-25 Pfizer Products Inc. Therapeutic combinations of atypical antipsychotics with gaba modulators, anticonvulsants or benzodiazapines
PT1691811E (pt) 2003-12-11 2014-10-30 Sunovion Pharmaceuticals Inc Combinação de um sedativo e de um modulador de neurotransmissores e métodos para melhorar a qualidade do sono e tratamento da depressão
BRPI0507190A (pt) * 2004-01-29 2007-06-26 Pfizer Prod Inc combinação de moduladores do ácido gama-aminobutìrico e antagonistas de 5-ht1b receptores
EP2275096A3 (en) 2005-08-26 2011-07-13 Braincells, Inc. Neurogenesis via modulation of the muscarinic receptors
EP2258357A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
WO2007047978A2 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by pde inhibition
EP2314289A1 (en) 2005-10-31 2011-04-27 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
CA2643199A1 (en) * 2006-03-08 2007-09-13 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
EP2021000A2 (en) 2006-05-09 2009-02-11 Braincells, Inc. Neurogenesis by modulating angiotensin
US20100009983A1 (en) * 2006-05-09 2010-01-14 Braincells, Inc. 5 ht receptor mediated neurogenesis
WO2008030651A1 (en) * 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
EP2066355A2 (en) * 2006-09-19 2009-06-10 Braincells, Inc. Combination comprising a peroxisome proliferator activated receptor agent and a second neurogenic agent for treating a nervous system disorder, increasing neurodifferentiation and increasing neurogenesis
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Also Published As

Publication number Publication date
DK106733C (da) 1967-03-13
US3242190A (en) 1966-03-22
AT249054B (de) 1966-09-26
BE656759A (da) 1965-06-08
FR4139M (da) 1966-05-02
IL22568A (en) 1968-04-25
AT250348B (de) 1966-11-10
ES306817A1 (es) 1965-05-16
GB1034939A (en) 1966-07-06
DK106796C (da) 1967-03-20
FR1427775A (fr) 1966-02-11
NL6414138A (da) 1965-06-07
ES306816A1 (es) 1965-05-16
DK106797C (da) 1967-03-20
SE303507B (da) 1968-09-02
DK108169C (da) 1967-10-02
DE1445848A1 (de) 1968-11-21
ES306820A1 (es) 1965-05-16
ES306819A1 (es) 1965-05-16
ES306818A1 (es) 1965-05-16
SE301652B (da) 1968-06-17
CH427803A (de) 1967-01-15

Similar Documents

Publication Publication Date Title
AR142945A1 (da)
FR4139M (da)
AT260747B (da)
BE627012A (da)
BE507458A (da)
BE462764A (da)
BE624070A (da)
BE612803A (da)
BE627023A (da)
BE626915A (da)
BE465565A (da)
BE635634A (da)
BE627025A (da)
BE626358A (da)
BE625880A (da)
BE626826A (da)
BE642909A (da)
BE626986A (da)
BE623162A (da)
BE625136A (da)
BE603935A (da)
BE614220A (da)
BE619061A (da)
BE625828A (da)
BE627141A (da)